I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 20% ± 7% | |
| epithelial cell | 6 studies | 31% ± 15% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 4 studies | 22% ± 3% | |
| CD8-positive, alpha-beta T cell | 4 studies | 21% ± 1% | |
| fibroblast | 4 studies | 21% ± 6% | |
| basal cell | 4 studies | 25% ± 10% | |
| B cell | 3 studies | 22% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 3% | |
| hematopoietic precursor cell | 3 studies | 25% ± 5% | |
| non-classical monocyte | 3 studies | 34% ± 9% | |
| neuron | 3 studies | 27% ± 13% | |
| precursor B cell | 3 studies | 18% ± 1% | |
| dendritic cell | 3 studies | 37% ± 7% | |
| natural killer cell | 3 studies | 22% ± 1% | |
| plasmacytoid dendritic cell | 3 studies | 23% ± 3% |
